MADISON, WI--(Marketwired - May 14, 2014) - Quincy Bioscience, manufacturer of the all-natural memory supplement Prevagen®, promotes Older Americans Month this May. The Wisconsin-based biotech company believes that older Americans should be provided with resources that help maintain healthy cognitive function and support optimal aging.
What was once known as Senior Citizens Month is now called Older Americans Month. Created by the Administration for Community Living (ACL), Older Americans Month is a time to honor older Americans by celebrating their contributions to our communities and provide them with information to stay healthy and active. This year's theme is "Safe Today. Healthy Tomorrow."
The baby boomer generation includes 78 million Americans who are living longer than any preceding generation and arguably leading fuller lives. By age 40, two-thirds of Americans experience occasional memory lapses, and by age 65, 25 percent suffer from mild memory problems associated with aging. Following these facts, the demand for products that preserve and promote health is growing.
For over six years, Quincy Bioscience has been promoting the benefits of the memory-enhancing ingredient called apoaequorin in its product Prevagen. Backed with published safety and efficacy studies, Prevagen has helped hundreds of thousands of customers through its distribution nationwide in drugstores, health food stores, and physician offices since the product was launched in 2007.
By helping people who are dealing with normal age-related memory loss, Prevagen has been coined the No. 1 brain health supplement in U.S. chain drug stores for several years according to Nielsen data.
About Quincy Bioscience
Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company's products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.